Cardiac Tissue Regeneration and Biosurgery

“This is great....The enthusiasm Dr. Boyd has in presenting this information is incredible.”

On March 10, 2011, W. Douglas Boyd, M.D., spoke about his work towards developing stem cell-based technologies to repair heart tissue damaged by cardiovascular disease. Boyd is a professor of surgery and director of robotics and biosurgery for the UC Davis Health System.

Boyd was introduced by Claire Pomeroy, M.D., M.B.A., vice chancellor for Human Health Sciences at UC Davis and dean of the UC Davis School of Medicine. Pomeroy is also a member of the CIRM Governing Board.

VIDEO: http://www.youtube.com/watch?v=QaB9GrpxRNU&feature=mfu_in_order&list=UL

Some interesting facts discussed about cardiovascular disease in the video:

• Cardiovascular disease affects 81.1 million Americans
• Cardiovascular disease is occurring more in women than men.
• In every year since 1900 (except 1918) CVD has been the leading cause of death.

In case you’re wondering, the number one cause of death in 1918 was the Spanish flu pandemic, which took at least 50 million lives.

This video is worth watching and provides a glimpse of where medicine is heading in the new millennium.

Thanks for showing me this, Mark!

Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011

Holly Huber shares her remarkable story about receiving stem cell therapy for Multiple Sclerosis (MS) at the Stem Cell Institute in Panama City, Panama. Ms. Huber was speaking at a seminar on stem cell therapy in Dallas, Texas.

Holly Huber speaks in Dallas, TX about her stem cell therapy experience for MS.

Holly’s website, www.ILoveMyNewStemCells.com, is a great place to learn more and can be found under the “Sites” section at anytime.

In the words of Holly:

I am sharing my experiences,
all the good and the bad,
with those who want to know more,
and those who are just curious,
even with those who think that only doctors
here in the United States of America
can perform  successful, life changing,
healing treatments.

Want to become a stem cell tracker? Here’s how.

Mark, a fellow visitor to StemCellTracker.com, sent me an e-mail asking if it is helpful to receive news tidbits from my readers and attached a link to a news article about Advanced Cell Technology.

Well Mark, the answer is a resounding YES. I even encourage it.

As you can see, the site can sometimes seem neglected when I don't have the time to update the headlines everyday.

While this is something I am working on, I encourage any readers interested in sharing information with the stem cell community to e-mail StemCellTracker@gmail.com and I will publish it for the world to see.

Mark's submission, ACT wins patent in China for stem cell manufacturing technique, talks about how Advanced Cell Technology (ACTC.OB) has secured patent protection in China for its process of making and preparing retinal pigment epithelial cells from human stem cells for use in treating macular degenerative diseases. The patent was awarded through China’s State Intellectual Property Office.

According to CEO Gary Rabin, “China is predicted to become the third-largest pharmaceutical market in the world later this year, and is an essential part of our global strategy. This patent allowance is an indicator of what we hope to achieve in the IP realm in Europe and elsewhere.”

I'm sure ACTC enthusiasts and investors, along with stem cell supporters worldwide, will be glad to hear about this. Thanks Mark!

Want to become a stem cell tracker? E-mail me and follow us on Twitter! ~ @StemCellTracker